Dyne Therapeutics SG&A Expense (Quarterly) Trends

Dyne Therapeutics Inc (DYN)

25.10 -0.34 (-1.34%) USD | NASDAQ | Apr 24, 15:24

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	8.844M
September 30, 2023	7.022M
June 30, 2023	7.606M
March 31, 2023	7.928M
December 31, 2022	6.955M
September 30, 2022	7.609M
June 30, 2022	6.091M
March 31, 2022	7.547M
December 31, 2021	9.659M

Date	Value
September 30, 2021	6.256M
June 30, 2021	6.293M
March 31, 2021	6.509M
December 31, 2020	6.502M
September 30, 2020	3.841M
June 30, 2020	1.341M
March 31, 2020	1.764M
December 31, 2019	1.211M
September 30, 2019	0.647M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

0.647M

Minimum

Sep 2019

9.659M

Maximum

Dec 2021

5.757M

Average

6.506M

Median

SG&A Expense (Quarterly) Benchmarks